Skip to main content
We may receive compensation from affiliate partners for some links on this site. Read our full Disclosure here.

WHO January Updated Guidance on Pfizer COVID-19 Jab: “No Efficacy or Safety Data for Children Below the Age of 12 Years”


On January 5th, 2022, the WHO updated its advice on the Pfizer-BioNTech COVID-19 injection.

What did the global health agency’s guidance include?

As stated by the WHO:

Who should not take the vaccine?

People with a history of severe allergic reaction to any component of the vaccine should not take it.

There are currently no efficacy or safety data for children below the age of 12 years. Until such data are available, individuals below 12 years of age should not be routinely vaccinated.

The WHO quietly noted they have no safety data for young children, yet we’re currently injecting 5-11-year-old children with this biological agent. 

Kids have zero statistical risk of severe COVID-19 complications, and giving them an experimental injection for this virus is barbaric. 

However, some states offer parents financial incentives to inoculate their 5-11-year-old children. 

The Defender noted the latest VAERS data for the age demographic:

U.S. VAERS data from Dec. 14, 2020, to Jan. 7, 2022, for 5- to 11-year-olds show:

  • 6,399 adverse events, including 142 rated as serious and 3 reported deaths.

The most recent death involves a 7-year-old girl (VAERS I.D. 1975356) from Minnesota who died 11 days after receiving her first dose of Pfizer’s COVID vaccine when she was found unresponsive by her mother. An autopsy is pending.

  • 14 reports of myocarditis and pericarditis (heart inflammation).
  • 22 reports of blood clotting disorders.

It’s criminal to inject a child with this experimental injection over a virus that’s essentially zero threat to their health.

The madness must stop!


Join the conversation!

Please share your thoughts about this article below. We value your opinions, and would love to see you add to the discussion!

Hey, Noah here!

Wondering where we went?

Read this and bookmark our new site!

See you over there!

Thanks for sharing!